Johan Strömqvist
Directeur/Bestuurslid bij NEWBURY PHARMACEUTICALS AB
Profiel
Johan Strömqvist is the founder of Single Technologies AB, where he holds the titles of President & Director since 2014.
He is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Dr. Strömqvist has a graduate degree from the University of Stockholm and graduate and doctorate degrees from the Royal Institute of Technology.
Actieve functies van Johan Strömqvist
| Bedrijven | Functie | Begin |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur/Bestuurslid | 01-01-2020 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Oprichter | 01-01-2014 |
Opleiding van Johan Strömqvist
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Commercial Services |
